Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 08:50 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | GA | 50 beds | Grade C | EBITDA uplift $2.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 113033 | CHATHAM, GA | 50 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 50-bed suburban community hospital in CHATHAM, GA with $27.8M in net patient revenue and a 19.7% operating margin. The hospital serves a payer mix of 60.2% Medicare, 1.2% Medicaid, and 38.6% commercial.

Thesis: Turnaround. Our ML models identify $2.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 19.7% to 27.1% (+736bps).

Net Revenue HCRIS$27.8M
Current EBITDA COMPUTED$5.5M
Operating Margin COMPUTED19.7%
Occupancy HCRIS93.3%
Revenue / Bed COMPUTED$555K
Net-to-Gross HCRIS71.2%
Distress Probability ML44.2%

2. Market Context & Competitive Position

165
GA Hospitals
-2.8%
State Median Margin
89
Comparable Hospitals

GA has 165 Medicare-certified hospitals with a median operating margin of -2.8%. The target's margin of 19.7% places it above the state median. Among 89 size-comparable peers (25-100 beds), the median margin is -3.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (25-100), prioritizing same-state peers. 89 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)GA50$27.8M19.7%
TANNER MEDICAL CENTER-VILLA RIGA58$289.8M33.3%
NORTHSIDE HOSPITAL - DULUTHGA87$193.2M-3.1%
ADVENTHEALTH GORDONGA69$188.5M-3.4%
COLQUITT REGIONAL MEDICAL CENTGA99$173.8M-17.0%
KENNESTONE HOSPITAL AT WINDY HGA55$160.5M0.7%
PIEDMONT NEWTON HOSPITALGA94$148.5M4.8%
COFFEE REGIONAL MEDICAL CENTERGA82$141.6M-10.3%
PIEDMONT COLUMBUS REGIONAL NORGA71$135.5M21.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$583K+210bp18mo
Cost to Collect4.5%2.5%$555K+200bp12mo
Denial Rate Reduction12.0%6.5%$550K+198bp12mo
A/R Days Reduction5200.0%3800.0%$338K+122bp9mo
Clean Claim Rate88.0%96.0%$18K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$583K
Cost to Collect
$555K
Denial Rate Reduction
$550K
A/R Days Reduction
$338K
Clean Claim Rate
$18K
Total EBITDA Uplift$2.0M
Current EBITDA$5.5M
+ RCM Uplift+$2.0M
Pro Forma EBITDA$7.5M
Current Margin19.7%
Pro Forma Margin27.1%
WC Released (1x)$1.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$8.4M$56.6M6.71x46.3%
Base (11x exit)10.0x11.0x$8.4M$65.0M7.71x50.4%
Bull Case9.0x11.0x$7.6M$74.5M9.81x57.9%
Bull (12x exit)9.0x12.0x$7.6M$83.5M11.00x61.5%
Bear Case11.0x10.0x$9.3M$43.6M4.70x36.3%
Bear (11x exit)11.0x11.0x$9.3M$51.0M5.50x40.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 60.2% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 89 hospitals with 25-100 beds
  • Same-state prioritization (n=90)
  • Comp margins: P25=-16.7% / P50=-3.4% / P75=5.2%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.